Pooled Genome Linkage Scan of Aggressive Prostate Cancer: Results from the International Consortium for Prostate Cancer Genetics

While it is widely appreciated that prostate cancers vary substantially in their propensity to progress to a life-threatening stage, the molecular events responsible for this progression have not been identified. Understanding these molecular mechanisms could provide important prognostic information relevant to more effective clinical management of this heterogeneous cancer. Hence, through genetic linkage analyses, we examined the hypothesis that the tendency to develop aggressive prostate cancer may have an important genetic component. Starting with 1,233 familial prostate cancer families with genome scan data available from the International Consortium for Prostate Cancer Genetics, we selected those that had at least three members with the phenotype of clinically aggressive prostate cancer, as defined by either high tumor grade and/or stage, resulting in 166 pedigrees (13%). Genome-wide linkage data were then pooled to perform a combined linkage analysis for these families. Linkage signals reaching a suggestive level of significance were found on chromosomes 6p22.3 (LOD = 3.0), 11q14.1-14.3 (LOD = 2.4), and 20p11.21-q11.21 (LOD = 2.5). For chromosome 11, stronger evidence of linkage (LOD = 3.3) was observed among pedigrees with an average at diagnosis of 65 years or younger. Other chromosomes that showed evidence for heterogeneity in linkage across strata were chromosome 7, with the strongest linkage signal among pedigrees without male-to-male disease transmission (7q21.11, LOD = 4.1), and chromosome 21, with the strongest linkage signal among pedigrees that had African American ancestry (21q22.13-22.3; LOD = 3.2). Our findings suggest several regions that may contain genes which, when mutated, predispose men to develop a more aggressive prostate cancer phenotype. This provides a basis for attempts to identify these genes, with potential clinical utility for men with aggressive prostate cancer and their relatives.

Citing Articles

Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.

Saunders E, Kote-Jarai Z, Eeles R Cancers (Basel). 2021; 13(4).

PMID: 33673083 PMC: 7917798. DOI: 10.3390/cancers13040760.

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.

Schaid D, McDonnell S, FitzGerald L, DeRycke L, Fogarty Z, Giles G Eur Urol. 2020; 79(3):353-361.

PMID: 32800727 PMC: 7881048. DOI: 10.1016/j.eururo.2020.07.038.

ANO7 is associated with aggressive prostate cancer.

Kaikkonen E, Rantapero T, Zhang Q, Taimen P, Laitinen V, Kallajoki M Int J Cancer. 2018; 143(10):2479-2487.

PMID: 30157291 PMC: 6589920. DOI: 10.1002/ijc.31746.

Prostate cancer susceptibility gene is a modulator of androgen receptor signaling and epithelial to mesenchymal transition.

Williams K, Lee M, Winter J, Gildea D, Calagua C, Curry N Oncotarget. 2018; 9(47):28532-28546.

PMID: 29983878 PMC: 6033342. DOI: 10.18632/oncotarget.25536.

Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.

Winter J, Curry N, Gildea D, Williams K, Lee M, Hu Y BMC Genomics. 2018; 19(1):450.

PMID: 29890952 PMC: 5996485. DOI: 10.1186/s12864-018-4827-2.

References

Chang B, Isaacs S, Wiley K, Gillanders E, Zheng S, Meyers D . Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease. Prostate. 2005; 64(4):356-61. DOI: 10.1002/pros.20249. View

Xu J . Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet. 2000; 66(3):945-57. PMC: 1288175. DOI: 10.1086/302807. View

Carter B, Bova G, Beaty T, Steinberg G, Childs B, Isaacs W . Hereditary prostate cancer: epidemiologic and clinical features. J Urol. 1993; 150(3):797-802. DOI: 10.1016/s0022-5347(17)35617-3. View

Xu J, Gillanders E, Isaacs S, Chang B, Wiley K, Zheng S . Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate. 2003; 57(4):320-5. DOI: 10.1002/pros.10306. View

Stanford J, McDonnell S, Friedrichsen D, Carlson E, Kolb S, Deutsch K . Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate. 2005; 66(3):317-25. DOI: 10.1002/pros.20349. View

Kruglyak L, Daly M, Lander E . Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996; 58(6):1347-63. PMC: 1915045. View

Witte J, Suarez B, Thiel B, Lin J, Yu A, Banerjee T . Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate. 2003; 57(4):298-308. DOI: 10.1002/pros.10304. View

Wiklund F, Gillanders E, Albertus J, Bergh A, Damber J, Emanuelsson M . Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate. 2003; 57(4):290-7. DOI: 10.1002/pros.10303. View

Lin D . An efficient Monte Carlo approach to assessing statistical significance in genomic studies. Bioinformatics. 2004; 21(6):781-7. DOI: 10.1093/bioinformatics/bti053. View

10.

Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G . Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet. 1998; 62(6):1416-24. PMC: 1377158. DOI: 10.1086/301879. View

11.

Jemal A, Tiwari R, Murray T, Ghafoor A, Samuels A, Ward E . Cancer statistics, 2004. CA Cancer J Clin. 2004; 54(1):8-29. DOI: 10.3322/canjclin.54.1.8. View

12.

Neville P, Conti D, Paris P, Levin H, Catalona W, Suarez B . Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia. 2002; 4(5):424-31. PMC: 1564121. DOI: 10.1038/sj.neo.7900254. View

13.

Paiss T, Worner S, Kurtz F, Haeussler J, Hautmann R, Gschwend J . Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families. Eur J Hum Genet. 2003; 11(1):17-22. DOI: 10.1038/sj.ejhg.5200898. View

14.

Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J . Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 2002; 30(2):181-4. DOI: 10.1038/ng823. View

15.

Witte J, Goddard K, Conti D, Elston R, Lin J, Suarez B . Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet. 2000; 67(1):92-9. PMC: 1287106. DOI: 10.1086/302960. View

16.

Schaid D . The complex genetic epidemiology of prostate cancer. Hum Mol Genet. 2004; 13 Spec No 1:R103-21. DOI: 10.1093/hmg/ddh072. View

17.

Xu J, Zheng S, Hawkins G, Faith D, Kelly B, ISAACS S . Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet. 2001; 69(2):341-50. PMC: 1235306. DOI: 10.1086/321967. View

18.

Etzioni R, Penson D, Legler J, di Tommaso D, Boer R, Gann P . Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94(13):981-90. DOI: 10.1093/jnci/94.13.981. View

19.

Whittemore A, Halpern J . Problems in the definition, interpretation, and evaluation of genetic heterogeneity. Am J Hum Genet. 2001; 68(2):457-65. PMC: 1235278. DOI: 10.1086/318186. View

20.

Hsieh C, Oakley-Girvan I, Balise R, Halpern J, Gallagher R, Wu A . A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet. 2001; 69(1):148-58. PMC: 1226029. DOI: 10.1086/321281. View